These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 29729083)

  • 41. Additive inhibition of nicotinic acetylcholine receptors by corticosteroids and the neuromuscular blocking drug vecuronium.
    Kindler CH; Verotta D; Gray AT; Gropper MA; Yost CS
    Anesthesiology; 2000 Mar; 92(3):821-32. PubMed ID: 10719961
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The steroid promegestone is a noncompetitive antagonist of the Torpedo nicotinic acetylcholine receptor that interacts with the lipid-protein interface.
    Blanton MP; Xie Y; Dangott LJ; Cohen JB
    Mol Pharmacol; 1999 Feb; 55(2):269-78. PubMed ID: 9927618
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular mechanisms of inhibition of nicotinic acetylcholine receptors by tricyclic antidepressants.
    Gumilar F; Arias HR; Spitzmaul G; Bouzat C
    Neuropharmacology; 2003 Dec; 45(7):964-76. PubMed ID: 14573389
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Selectivity of coronaridine congeners at nicotinic acetylcholine receptors and inhibitory activity on mouse medial habenula.
    Arias HR; Jin X; Feuerbach D; Drenan RM
    Int J Biochem Cell Biol; 2017 Nov; 92():202-209. PubMed ID: 29042244
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Action of nereistoxin on recombinant neuronal nicotinic acetylcholine receptors expressed in Xenopus laevis oocytes.
    Raymond Delpech V; Ihara M; Coddou C; Matsuda K; Sattelle DB
    Invert Neurosci; 2003 Nov; 5(1):29-35. PubMed ID: 14608492
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structural determinants in phycotoxins and AChBP conferring high affinity binding and nicotinic AChR antagonism.
    Bourne Y; Radic Z; Aráoz R; Talley TT; Benoit E; Servent D; Taylor P; Molgó J; Marchot P
    Proc Natl Acad Sci U S A; 2010 Mar; 107(13):6076-81. PubMed ID: 20224036
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potentiation and inhibition of neuronal nicotinic receptors by atropine: competitive and noncompetitive effects.
    Zwart R; Vijverberg HP
    Mol Pharmacol; 1997 Nov; 52(5):886-95. PubMed ID: 9351980
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Roles of amino acids and subunits in determining the inhibition of nicotinic acetylcholine receptors by competitive antagonists.
    Dilger JP; Vidal AM; Liu M; Mettewie C; Suzuki T; Pham A; Demazumder D
    Anesthesiology; 2007 Jun; 106(6):1186-95. PubMed ID: 17525594
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hydrocortisone and 11-desoxycortisone modify acetylcholine receptor channel gating.
    Bouzat C; Barrantes FJ
    Neuroreport; 1993 Feb; 4(2):143-6. PubMed ID: 8453051
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tryptophan 86 of the alpha subunit in the Torpedo nicotinic acetylcholine receptor is important for channel activation by the bisquaternary ligand suberyldicholine.
    Kapur A; Davies M; Dryden WF; Dunn SM
    Biochemistry; 2006 Aug; 45(34):10337-43. PubMed ID: 16922509
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Positive and negative modulation of nicotinic receptors.
    Arias HR
    Adv Protein Chem Struct Biol; 2010; 80():153-203. PubMed ID: 21109220
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identified spinal motoneurons of young rats possess nicotinic acetylcholine receptors of the heteromeric family.
    Ogier R; Liu X; Tribollet E; Bertrand D; Raggenbass M
    Eur J Neurosci; 2004 Nov; 20(10):2591-7. PubMed ID: 15548202
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Curare binding and the curare-induced subconductance state of the acetylcholine receptor channel.
    Strecker GJ; Jackson MB
    Biophys J; 1989 Oct; 56(4):795-806. PubMed ID: 2479422
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Allosteric modifiers of neuronal nicotinic acetylcholine receptors: new methods, new opportunities.
    Moaddel R; Jozwiak K; Wainer IW
    Med Res Rev; 2007 Sep; 27(5):723-53. PubMed ID: 17238157
    [TBL] [Abstract][Full Text] [Related]  

  • 55. M2 mutations of the nicotinic acetylcholine receptor increase the potency of the non-competitive inhibitor phencyclidine.
    Eaton MJ; Labarca C; Eterovíc VA
    J Neurosci Res; 2000 Jul; 61(1):44-51. PubMed ID: 10861798
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activation kinetics of recombinant mouse nicotinic acetylcholine receptors: mutations of alpha-subunit tyrosine 190 affect both binding and gating.
    Chen J; Zhang Y; Akk G; Sine S; Auerbach A
    Biophys J; 1995 Sep; 69(3):849-59. PubMed ID: 8519985
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Noncompetitive inhibition of nicotinic acetylcholine receptors by endogenous molecules.
    Arias HR
    J Neurosci Res; 1998 May; 52(4):369-79. PubMed ID: 9589382
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of interaction of 3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester with Torpedo californica nicotinic acetylcholine receptor and 5-hydroxytryptamine3 receptor.
    Sun H; McCardy EA; Machu TK; Blanton MP
    J Pharmacol Exp Ther; 1999 Jul; 290(1):129-35. PubMed ID: 10381768
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Noncompetitive antagonist binding sites in the torpedo nicotinic acetylcholine receptor ion channel. Structure-activity relationship studies using adamantane derivatives.
    Arias HR; Trudell JR; Bayer EZ; Hester B; McCardy EA; Blanton MP
    Biochemistry; 2003 Jun; 42(24):7358-70. PubMed ID: 12809491
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serotonin antagonizes the human neuronal alpha7 nicotinic acetylcholine receptor and becomes an agonist after L248T alpha7 mutation.
    Fucile S; Palma E; Eusebi F; Miledi R
    Neuroscience; 2002; 110(1):169-79. PubMed ID: 11882381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.